Nair Vinay’s Impax Laboratories, Inc. IPXL Stock Holding History

Nair Vinay’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,590	Closed	-$262K	–	411
2015 Q1	$262K	Buy	+5,590	New	+$222K	0.18%	239

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Nair Vinay's IPXL Position: Q2 2015 in Review

Nair Vinay sold out of Impax Laboratories, Inc. (IPXL) in Q2 2015, closing a stake of 5,590 shares — an estimated $262K sold.

Nair Vinay first reported a position in IPXL in Q1 2015 and held it in 1 quarter. The position peaked at $262K in Q1 2015. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

Nair Vinay reported no remaining Impax Laboratories, Inc. position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 5,590 Impax Laboratories, Inc. shares in Q2 2015, an estimated $262K.
Nair Vinay first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 1 quarter.
Nair Vinay's Impax Laboratories, Inc. position peaked at $262K in Q1 2015.
197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.